BeOne Medicines Ltd. - ADR (ONC) Earnings

ONC Earnings Reports

Positive Surprise Ratio

ONC beat 5 of 17 last estimates.

29%

Next Report

Date of Next Report

Nov 04, 2026

Estimate for Q3 26 (Revenue/ EPS)

$12.77B

$1.09

Implied change from Q2 26 (Revenue/ EPS)

+10.96%

-92.12%

Implied change from Q3 25 (Revenue/ EPS)

+26.35%

+91.23%

BeOne Medicines Ltd. - ADR earnings per share and revenue

On Aug 05, 2026, ONC reported earnings of 13.83 USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 11.51 billion, compared to an expected --, with a --% difference. The market reacted with a +1.40% price change (close before vs. close after earnings).

Looking ahead to Q3 26, -- analysts forecast an EPS of 1.09 USD, with revenue projected to reach 12.77 billion USD, implying an decrease of -92.12% EPS, and increase of 10.96% in Revenue from the last quarter.

FAQ

What were BeOne Medicines Ltd. - ADR's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, BeOne Medicines Ltd. - ADR reported EPS of $13.83, missing estimates by --, and revenue of $11.51B, -- -- expectations.

How did the market react to BeOne Medicines Ltd. - ADR's Q2 2026 earnings?

The stock price moved up 1.4%, changed from $323.01 before the earnings release to $327.53 the day after.

When is BeOne Medicines Ltd. - ADR expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for BeOne Medicines Ltd. - ADR's next earnings report?

Based on -- analysts, BeOne Medicines Ltd. - ADR is expected to report EPS of $1.09 and revenue of $12.77B for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.